United Consortium Ltd.

United Consortium Ltd.

UCSO
United Consortium Ltd.US flagOther OTC
0.00
USD
- -
- -
837.00Market Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Richard Hans Bach
Sector
Financial Services
Industry
Financial - Capital Markets
Address
PO Box 340746 Tampa FL United States of America 33694
IPO Date
Jun 2, 2010
Business
United Consortium Ltd United Consortium Ltd (UCSO), founded in 1999 and headquartered in Tampa, Florida, operates as an acquisition and development company focused on identifying and monetizing opportunities across multiple sectors including digital media, blockchain technology, medical cannabis cultivation and distribution, and computer telecommunications products and services. The company provides solutions in medical cannabis acquisition and development, such as strain cultivation, processing, and market distribution for therapeutic applications; blockchain-based platforms for secure transactions and digital asset management; digital media content creation, distribution, and monetization services; and telecommunications hardware distribution including networking equipment, connectivity solutions, and related support services. It targets healthcare providers, technology firms, and consumer markets primarily in the United States with potential expansion into international regions through strategic opportunities. Recent activities emphasize ongoing efforts to create shareholder value through opportunistic acquisitions and developments in high-growth areas like medical cannabis and emerging technologies, though no major partnerships, funding rounds, or new product launches have been publicly reported in the last 1-2 years.